Language

Pulmonary

MultiCare Pulmonary Specialists is a multi-physician group located in Tacoma, WA. The site employs an experienced research team comprised of board certified Pulmonologists, Study Coordinators, and an Administrative Assistant. The site is conveniently located near three hospitals and all clinical research is done on site. In addition, the site has a comprehensive patient database that is connected to all MultiCare facilities.

Research Director:

James R. Taylor, M.D., Medical Director for the site, has over twenty (20) years of research experience and has conducted over 150 trials. Dr. Taylor trained at Stanford University, University of California San Francisco and the University of Washington. Dr. Taylor is board certified in Pulmonary, Critical Care and Internal Medicine, and is the Medical Director of the ICU at Tacoma General Hospital.

Principal Investigators:

James R. Taylor, M.D., Board Certified Internal Medicine, Pulmonary, Critical Care
Stephen C. Ryan, M.D., Board Certified Internal Medicine, Pulmonary, Critical Care, Sleep Medicine

Sub-Investigators:

Arthur R. Knodel, M.D., Board Certified Internal Medicine, Pulmonary, Critical Care, Sleep Medicine
Edward J. LeDoux, M.D., Board Certified Internal Medicine, Pulmonary, Critical Care, Sleep Medicine
Thomas N. Mann, M.D., Board Certified Internal Medicine, Pulmonary, Critical Care
John H. Rowlands, M.D., Board Certified Internal Medicine, Pulmonary, Critical Care, Sleep Medicine

Research Interests:
  • Asthma
  • Allergy & Allergic Rhinitis
  • COPD
  • Smoking Cessation
  • Sleep Disorders
  • Cystic Fibrosis
  • Bronchiectasis

Pulmonary Studies Accepting Participants

Adult - COPD Ehtos
Study Number: PT010005-01—A randomized, double-blind, multi-center, parallel group study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations over a 52-week treatment period in subjects with moderate to very severe COPD.

Study Info

Principal Investigator(s): Stephen Ryan, MD

Study Coordinator: Kelly Mulligan, [email protected], 253-403-0389
Adult - PT009002 COPD
Study Number: PT009002-00—A randomized, double-blind, parallel group, multicenter study to assess the efficacy and safety of PT009 compared to PT005, PT008, and open-label Symbicort® Turbuhaler®, as an active control, on lung function over a 24-week treatment period in subjects with moderate to very severe COPD.

Study Info

Principal Investigator(s): Stephen Ryan, MD

Study Coordinator: Kelly Mulligan, [email protected], 253-403-0389
Adult - Terranova COPD
Study NumberTERRANOVA—A randomized, double-blind, double dummy, 56-week placebo-controlled, multicenter, parallel group, Phase III study evaluating efficacy/safety of 3 Benralizumab doses in patients with moderate to very severe COPD with

previous exacerbations.

Study Info

Principal Investigator(s): Stephen Ryan, MD

Study Coordinator: Jami Smith, [email protected], 253-403-0389
Adult - Mereo COPD
Study NumberMEREO—A Phase II, two-part, randomized, multi-center, multinational, double-blind, placebo-controlled, parallel group study to compare the efficacy and safety of BCT197 when added on to standard of care for the treatment of acute

respiratory exacerbations of chronic obstructive pulmonary disease requiring hospitalization in adults.

Study Info

Principal Investigator(s): Stephen Ryan, MD

Study Coordinator: Kelly Mulligan, [email protected], 253-403-0389